Michael G Case Selected Research

Protein Isoforms (Isoforms)

1/2018

Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael G Case Research Topics

Disease

3	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 03/2016
3	Schizophrenia (Dementia Praecox) 01/2014 - 01/2011
2	Migraine Disorders (Migraine) 08/2019 - 01/2019
2	Pain (Aches) 08/2019 - 01/2019
2	Headache (Headaches) 08/2019 - 01/2019
2	Dementia (Dementias) 01/2018 - 03/2016
1	Epilepsy (Aura) 01/2019
1	Atrophy 01/2019
1	Bipolar Disorder (Manic Depressive Psychosis) 05/2006
1	Mania (Manias) 05/2006

Drug/Important Bio-Agent (IBA)

4	Olanzapine (Zyprexa)FDA Link 01/2014 - 05/2006
3	solanezumabIBA 01/2019 - 03/2016
2	Pain-FreeIBA 08/2019 - 01/2019
2	lasmiditanIBA 08/2019 - 01/2019
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 03/2016
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	5-HT1F Serotonin ReceptorIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2018
1	florbetapirIBA 03/2016
1	Antipsychotic Agents (Antipsychotics)IBA 01/2014
1	olanzapine-fluoxetine combination (Symbyax)FDA Link 05/2006

Therapy/Procedure

1	Intravenous Infusions 01/2019
1	Injections 01/2014